Showing results (1311-1320 of 1,568) with videos related to

Sort By:
Pageof 157
Blood|October 28, 2010
First use of thymus transplantation therapy for FOXN1 deficiency (nude/SCID): a report of 2 casesM Louise Markert, José G Marques, Bénédicte Neven, et al.
The Journal of Allergy and Clinical Immunology|April 22, 2004
Complete DiGeorge syndrome: development of rash, lymphadenopathy, and oligoclonal T cells in 5 casesM Louise Markert, Marilyn J Alexieff, Jie Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 6, 2012
Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancerPaola Tucci, Massimiliano Agostini, Francesca Grespi, et al.
Plos One|May 17, 2011
Benchmarking of mutation diagnostics in clinical lung cancer specimensSilvia Querings, Janine Altmüller, Sascha Ansén, et al.
Human Gene Therapy. Clinical Development|March 22, 2014
Evaluation of the safety and biodistribution of M032, an attenuated herpes simplex virus type 1 expressing hIL-12, after intracerebral administration to aotus nonhuman primatesJustin C Roth, Kevin A Cassady, James J Cody, et al.
Scientific Reports|May 26, 2026
Enhancing sleep slow waves with auditory stimulation in people with Parkinson's disease: a randomized proof-of-concept trialSimon J Schreiner, Jana Horlacher, Sara Fattinger, et al.
Environmental Pollution (Barking, Essex : 1987)|September 6, 2021
From mine to mind and mobiles - Lithium contamination and its risk managementNanthi Bolan, Son A Hoang, Mohsin Tanveer, et al.
The Journal of Clinical Investigation|October 1, 2019
FOXN1 compound heterozygous mutations cause selective thymic hypoplasia in humansQiumei Du, Larry K Huynh, Fatma Coskun, et al.
Archivos Espanoles De Urologia|October 16, 2018
[Immunotherapy in castration resistant prostate cancer.]Bernardino Miñana López, Felipe Villacampa Aubá, Fernando Ramón de Fata Chillón, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2022
Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS CancersKyung-Don Kang, Joshua D Bernstock, Stacie K Totsch, et al.
Pageof 157